SBIR-STTR Award

Development of a Microfluidic Device for Rapid Analysis, Sorting, and Collection of Biological Particles using Photonic Forces
Award last edited on: 5/12/2005

Sponsored Program
SBIR
Awarding Agency
NSF
Total Award Amount
$599,711
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Catherine A Schnabel

Company Information

Genoptix Inc (AKA: Genoptix Medical Laboratory~DNA Dynamics, Inc)

1811 Aston Avenue
Carlsbad, CA 92008
   (760) 268-6200
   info@genoptix.com
   www.genoptix.com
Location: Single
Congr. District: 49
County: San Diego

Phase I

Contract Number: ----------
Start Date: ----    Completed: ----
Phase I year
2003
Phase I Amount
$99,771
This Small Business Innovation Research (SBIR) Phase I project propses to demonstrate that moving optical gradient forces, Optophoresis, provide selective and sensitive analysis and sorting of cells important to optimizing bioreactor production processes. Isolation of stable cell populations, as related to functional phenotype, and maximizing viable cell density are critical to the efficient and economic production of protein-based therapeutic agents. The ability to remove pro-apoptotic cells will significantly improve bioprocess technology. This Phase I effort will demonstrate the analysis, sorting, and recovery of non-apoptotic cells for further manipulations, and the isolation of cells with certain biological characteristics, for example secretion levels. In a microsorter device, cells will be simultaneously analyzed and sorted by the optical gradient force based on the native cell characteristics (such as size, morphology, dielectric properties etc.). The objectives of the Phase I project are : 1) to build an optical and microfluidics workstation; 2) to fabricate microfluidic devices for aseptic loading and recovery of cells, 3) to identify and characterize apoptotic and secretor cell models, 4) to demonstrate that Optophoresis can discriminate between different cell subpopulations, and 5) to collect sorted populations for further manipulations. In the follow on Phase II project, the microsorter instrument will be further developed for both research and continuous on-line monitoring needs. The commercial applications of this project include bioprocess engineering, clinical diagnostics, cancer testing, environmental monitoring, tissue engineering, and drug discovery

Phase II

Contract Number: ----------
Start Date: ----    Completed: ----
Phase II year
2004
Phase II Amount
$499,940
This Small Business Innovation Research (SBIR) Phase II project will develop a fluorescence activated cell sorter (FACS) that uses optical forces to move cells and to sort cell sub-populations. The specific Phase II objectives are : (1) to build an integrated prototype cell sorter with flexibility to configure multiple lasers and detectors, (2) to develop a self contained microfluidic cartridge that can handle 1,000-100,000 cells/sample and sort with purities greater than 95% and total recovery rates greater than 80%, (3) to develop microfluidic flow assays, and (4) to validate that the mechanical and optical stresses do not adversely affect cells. The proposed work will result in a prototype cell sorter, self-contained microfluidic cartridges, and a panel of assays that demonstrate the broad utility of the instrument. The commercial application of this project will be in the area of cell-based assays for use in biological and biomedical research